IBRNvsPOWA
iShares Neuroscience and Healthcare ETF against INVESCO DEFENSIVE EQUITY ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | POWA | |
|---|---|---|
| Expense ratio | 0.47% | — |
| Assets | $6640.17T | $164M |
| Net flow, 1 month | −$60K | −$4M |
| Net flow, 1 year | +$2M | −$19M |
| Return, YTD | +1.7% | -3.4% |
| Return, 1 year | +22.3% | -4.3% |
| Avg daily volume | 2K | 2K |
| Holdings | 54 | 0 |
| Listed | Aug 24, 2022 | Mar 17, 2024 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS